PTCT PEER ANALYSIS

PTC Therapeutics Inc — metric-by-metric comparison with peers and the industry median

PTCTPTC Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

PTCTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PTCT	TLX	CSL	MSB	Ind. Median
P/E	—	—	29.96	—	18.06
P/B	-40.79●	6.38	2.24	—	3.62
EV/EBITDA	—	120.20	10.35●	—	15.13
P/S	8.90	3.24	2.66●	31.30	10.65

Financial Health
Metric	PTCT	TLX	CSL	MSB	Ind. Median
Current Ratio	2.44	1.43	2.57●	—	5.90
Debt/Equity	-218.9%●	112.3%	67.4%	—	10.9%
NetDebt/EBITDA	12.52	13.13	2.22●	—	1.15

Profitability
Metric	PTCT	TLX	CSL	MSB	Ind. Median
Net Margin	-22.6%	-0.9%	9.2%●	-115.3%	-125.7%
ROE	—	-1.8%	7.7%●	-11.3%	-47.5%
ROA	-6.8%	-0.7%	3.8%●	-8.6%	-35.8%
EBITDA Margin	-14.5%	3.0%	32.8%●	-76.6%	-105.8%

Growth + Dividend
Metric	PTCT	TLX	CSL	MSB	Ind. Median
Rev. Growth	-53.3%	56.3%	4.8%	410.4%●	5.1%
NI Growth	—	—	-39.4%	—	12.1%
Div. Yield	—	—	2.5%●	0.0%	0.2%
Payout	—	—	103.1%	0.0%	0.0%

Valuation
Metric	PTCT	SRRK	ACLX	MIRM	LGND	RYTM	Ind. Median
P/E	—	—	-28.30●	—	41.36	—	18.06
P/B	-40.79●	26.08	16.10	31.14	6.37	63.30	3.62
EV/EBITDA	—	—	-30.94●	—	27.11	—	15.13
P/S	8.90●	—	290.72	13.26	23.14	35.83	10.65

Financial Health
Metric	PTCT	SRRK	ACLX	MIRM	LGND	RYTM	Ind. Median
Current Ratio	2.44	8.64	4.44	2.09	21.28●	4.17	5.90
Debt/Equity	-218.9%●	74.5%	23.9%	133.5%	45.3%	184.7%	10.9%
NetDebt/EBITDA	12.52	0.69	1.79	0.08	-1.47●	0.63	1.15

Profitability
Metric	PTCT	SRRK	ACLX	MIRM	LGND	RYTM	Ind. Median
Net Margin	-22.6%	—	-1,027.3%	-140.2%	55.9%●	-93.3%	-125.7%
ROE	—	-138.9%	-53.4%	-335.8%	17.1%●	-141.7%	-47.5%
ROA	-6.8%	-86.7%	-34.8%	-101.0%	12.6%●	-48.9%	-35.8%
EBITDA Margin	-14.5%	—	-888.3%	-133.6%	81.0%●	-83.2%	-105.8%

Growth + Dividend
Metric	PTCT	SRRK	ACLX	MIRM	LGND	RYTM	Ind. Median
Rev. Growth	-53.3%	—	-79.4%	50.2%	51.2%	58.7%●	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	0.1%	0.2%
Payout	—	—	—	—	—	-2.0%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PTCT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.